サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：チャネル血液凝固計の世界市場-2022-2029
市場調査レポート
商品コード
1129262

チャネル血液凝固計の世界市場-2022-2029

Global Channel Coagulometer Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 160 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
チャネル血液凝固計の世界市場-2022-2029
出版日: 2022年09月29日
発行: DataM Intelligence
ページ情報: 英文 160 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場力学

チャネル血液凝固計の革新は、市場の成長を促進することが期待されます。

Medsource Ozone Biomedicalsによって作成された現代の4チャンネル光凝固アナライザーは、ユーザーの快適さのためのタッチスクリーンインターフェイス最新の血栓検出技術を備えています。

さらに、2021年10月20日に凝固部門に革新的な新製品が発売され、臨床成績と生産性を向上させました。Diagon Ltd.製の凝固分析装置製品のデビューは、医療機器の著名なプロバイダーであるTrivitronヘルスケアによって発表されました。提携契約を締結した後、TrivitronはDiagon-Vanguard Diagnostics Indiaと共同でインドの診断市場向けにこれらの製品の発売を発表しました。この発売は、患者管理を拡大し、臨床的な意思決定の有効性を向上させるため、医療界にとって良い兆しとなります。ディアゴン・ハンガリー社が製造するCOAGライン自動・半自動・POCシステムは、新製品の一つです。これらは、抗凝固薬や止血治療の効果を評価し、広範な処置の際の出血リスクを軽減するために使用されます。このように、上記の記述から、予測期間中に市場が牽引されることが予想されます。

抑制要因

分析装置のコスト高、厳しい規制当局の承認、分析装置を管理する熟練した専門家の不足が、予測期間中に市場が阻害される要因であると考えられます。

産業分析

チャネル血液凝固計市場は、サプライチェーン、価格分析、規制分析などの様々な産業要因に基づいて、市場の詳細な分析を提供します。

COVID-19の影響分析

COVID-19のパンデミックは、市場に中程度の影響を及ぼしています。パンデミックの間、COVID-19凝固障害に関連した出血や血栓症状の頻度を理解し、出血や血栓症の可能性、病気の重症度を特定するために凝固異常検査の臨床的価値を理解することが極めて重要です。Dダイマーのほか、プロトロンビン時間（PT）の延長も、生存率の低下や重症患者への対応の必要性と関連があるとされています。播種性血管内凝固症候群（DIC）は、感染症で死亡する患者の70％以上に関連し、検査結果に基づいて記述されています。その結果、チャネルコアグロメーターは、より需要が高まっています。一方、COVID-19はサプライチェーンを弱体化させ、チャネルコアグロメーター製品の世界の不足を生じさせました。このように、COVID-19の大流行が市場に影響を及ぼしています。しかし、この状況は予測期間中に徐々に改善されると予想されます。

世界のチャネル血液凝固計市場レポートは、約45+市場データ表、40+図と160ページへのアクセスを提供するでしょう。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場の力学

  • 市場影響要因
    • 促進要因
      • チャネルコアグロメーターの革新が市場成長を促進すると予想されます。
    • 抑制要因
      • 分析装置の高コストが予測期間中に妨げになると予想されます。
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターの5つの力
  • アンメットニーズ
  • サプライチェーン
  • プライシング分析

第6章 COVID-19分析

  • COVID-19の市場分析
    • COVID-19発売前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • まとめ

第7章 製品タイプ別

  • 2チャンネル凝固計
  • 4チャンネル凝固計
  • 6チャンネル凝固計
  • 7チャンネル凝固計
  • 8チャンネル凝固計

第8章 モダリティタイプ別

  • スタンドアローン型血液凝固計
  • 卓上型血液凝固測定装置
  • ハンドヘルド・ポータブル血液凝固計
  • その他

第9章 エンドユーザー別

  • 病院
  • 学術・研究機関
  • 受託研究機関
  • 診断機関
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • 製品ベンチマーク
  • 注目の主要企業リスト

第12章 企業プロファイル

  • HORIBA Medical
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • LINEAR CHEMICALS S.L.U.
  • BioSystems S.A.
  • Rayto Life and Analytical Sciences Co.,Ltd.
  • Micro Lab Instruments
  • TECO Medical Instruments
  • Helena Biosciences
  • Genrui Biotech Inc.
  • Biobase
  • Maccura Biotechnology Co., Ltd.

第13章 チャネル血液凝固計の世界市場-DataM

目次
Product Code: DMCD5847

Market Overview

Channel Coagulometer Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of YY % during the forecast period (2022-2029).

A blood coagulometer is an analyzer used to test the coagulation efficiency of blood to diagnose and assess bleeding disorders such as hemophilia or monitor patients taking anticoagulant medicines such as aspirin, heparin, or warfarin. There are six to seven different kinds, including the two-channel coagulometer, four-channel coagulometer, six-channel coagulometer, seven-channel coagulometer, and eight-channel coagulometer, and so on. Moreover, it also assists doctors in developing individualized antiplatelet therapy.

Market Dynamics

Innovations in the channel coagulometer are expected to drive market growth.

A modern four-channel photo-optical coagulation analyzer created by Medsource Ozone Biomedicals features a touch screen interface for user comfort latest clot detection technology. Three reagent stations and 22 sample positions for incubation, automatic optical start, LED technology Results in INR, Ratio, Quick%, Low reagent and sample volume required, no bars or stirrers needed, an instrument that requires no upkeep Can perform four tests at once (simultaneously), Compatibility with PT, aPTT, TT, FIB, D-Dimer, Factors, Protein C, Protein S, and essentially any Hemostasis assay, etc. Observations from 180 patients.

Moreover, an innovative new product was launched in the Coagulation segment on October 20, 2021, to improve clinical outcomes and productivity. The debut of a new line of Coagulation Analyzer products made by Diagon Ltd. has been announced by Trivitron Healthcare, a prominent provider of medical devices. After signing a collaboration agreement, Trivitron announced the launch of these products for the Indian diagnostics market in collaboration with Diagon-Vanguard Diagnostics India. This launch bodes well for the medical community because it expands patient management and improves clinical decision-making effectiveness. The COAG Line automated, semi-automated, and POC systems produced by Diagon Hungary are among the new products. They are used to assess the effectiveness of anticoagulant medications and hemostatic therapy and to reduce the risk of bleeding during extensive procedures. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

The high cost of the analyzers, stringent regulatory approvals, and lack of skilled professionals for managing the analyzers are the factors the market is expected to get hampered in the forecast period.

Industry Analysis

The channel coagulometer market provides in-depth analysis of the market based on various industry factors such as supply chain, pricing analysis, regulatory analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted the market. During the pandemic, it is crucial to comprehend the frequency of bleeding and thrombotic symptoms linked to COVID-19 coagulopathy, as well as the clinical value of abnormal coagulation testing to identify the likelihood of bleeding, thrombosis, and the severity of the sickness. Besides D-dimer, a prolonged prothrombin time (PT) has also been linked to a lower chance of survival and a greater demand for critical care. Disseminated intravascular coagulation (DIC), linked to >70% of patients who die from the infection, has been described based on test results. As a result, the channel coagulometer is now more in demand. In contrast, COVID-19 has weakened the supply chain and created a global shortage of channel coagulometer products. Thus, the COVID-19 pandemic has affected the market. However, the situation is expected to improve gradually in the forecast period.

Segment Analysis

Hospital segment is expected to hold the largest market share in channel coagulometer market.

The hospital segment accounted for the largest market share in 2021. The increasing number of hospitals and their growing infrastructure are the factors to drive the market growth. For instance, in 2020, Colombia had the highest hospital count, around 10,899. In comparison, Japan had around 8,238 hospitals. Moreover, as of November 18, 2021, 80,136 Ayushman Bharat-Health and Wellness Centres (AB-HWCs) are operational in India. As of November 18, 2021, 638 e-Hospitals are established across India as part of the central government's 'Digital India' initiative. Therefore, it has led to increasing demand for channel coagulometers. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global channel coagulometer market

In 2021, the North American channel coagulometer accounted for the highest revenue share in the global market. The increasing prevalence of blood clotting-related disorders, technological advancement in the channel coagulometer, well-established infrastructure, and product launches by the key market players are the factors that drive the market in the forecast period. For instance, Von Willebrand disease, the most prevalent genetic bleeding disorder in America brought on by clotting proteins, affects a lot more people. Both sexes are susceptible to Von Willebrand disease. Moreover, the most common inherited bleeding disorder among American women is a common cause of heavy menstrual bleeding and other bleeding problems in women and adolescent girls. Therefore, it has increased the demand for channel coagulometers in the region; thus, the North American region has the largest market share.

Competitive Landscape

Major key players in the channel coagulometer market are HORIBA Medical, LINEAR CHEMICALS S.L.U., BioSystems S.A., Rayto Life and Analytical Sciences Co.,Ltd., Micro Lab Instruments, TECO Medical Instruments, Helena Biosciences, Genrui Biotech Inc., Biobase and Maccura Biotechnology Co., Ltd.

Micro Lab Instruments:

Overview:

Micro Lab Instruments is one of India's fastest-growing diagnostic companies based in Ahmedabad, the Western state of India, established in 1993. The company manufacturers and exporters a wide range of Biochemistry Analyzer, Electrolyte Analyzer, Elisa Reader, Dry Bath Incubator, Elisa Plate Washer, Single Channel coagulometers and much more. The organization is supported by a team of experienced professionals, which directs its sincere and painstaking efforts to provide its customers with the best solution for their needs. Moreover, the company exports its products to countries including Egypt, Peru, Ethiopia, South Africa and Kenya.

Product Portfolio:

Single Channel Coagulometer:

Main Features:

  • Semi-automatic Single channel coagulometer
  • Printout of the graph and results
  • On-board storage capability up to 20 assays
  • Open system with user friendly software
  • All methods creatable, editable, copy and delete
  • Automated calculation results in seconds, %, INR, g/l, mg/dl, Ratio
  • Calibration/reference curves editable up to 9 measurement points
  • Automatic start-pipette connectable
  • Automated cuvette detection and calculation
  • Data transmission to SD-card or external PC (Optional)

The global channel coagulometer market report would provide an access to an approx. 45+market data table, 40+figures and 160pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations in the channel coagulometer are expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of the analyzers is expected to get hampered in the forecast period.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Unmet Needs
  • 5.3. Supply Chain
  • 5.4. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. 2 Channel Coagulometer*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. 4 Channel Coagulometer
  • 7.4. 6 Channel Coagulometer
  • 7.5. 7 Channel Coagulometer
  • 7.6. 8 Channel Coagulometer

8. By Modality Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 8.1.2. Market Attractiveness Index, By Modality Type Segment
  • 8.2. Stand-Alone Coagulometer*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Bench-Top Coagulometer
  • 8.4. Handhled/Protable Coagulometer
  • 8.5. Others

9. By End user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.1.2. Market Attractiveness Index, By End user Segment
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Academic & Research Institutions
  • 9.4. Contract Research Organization
  • 9.5. Diagnostic Laboratories
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. HORIBA Medical*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. LINEAR CHEMICALS S.L.U.
  • 12.3. BioSystems S.A.
  • 12.4. Rayto Life and Analytical Sciences Co.,Ltd.
  • 12.5. Micro Lab Instruments
  • 12.6. TECO Medical Instruments
  • 12.7. Helena Biosciences
  • 12.8. Genrui Biotech Inc.
  • 12.9. Biobase
  • 12.10. Maccura Biotechnology Co., Ltd.

LIST NOT EXHAUSTIVE

13. Global Channel Coagulometer Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Applications
  • 13.3. Contact Us